S4M-03294: Women’s Health

The motion

That the Parliament notes that an estimated 4,000 women in Scotland are believed to have received breast implants manufactured by Poly Implant Prothèse (PiP); supports the ongoing criminal investigation in France into the former owner of PiP, Jean Claude Mas, for his role in the manufacture and distribution of the substandard implants containing industrial grade silicone; further notes with concern that PiP’s activities remained undetected by regulators for a considerable period of time and the lack of information provided to the victims of the scandal, a number of whom only became aware of the potential dangers through news reports in December 2011, over a year after the medical device alert was issued by the Medicine and Healthcare products Regulatory Agency in March 2010; regrets the lottery of aftercare offered by the private clinics that carried out breast augmentation operations with PiP implants for women in Scotland, particularly the charging for replacement operations and attaching conditions to treatment such as the waiving of legal rights; further notes the Cabinet Secretary for Health, Wellbeing and Cities Strategy's assertion that it is only by chance that the NHS in Scotland did not use the potentially dangerous implants and that the true scale of the scandal in Scotland may never be known, and calls on the Scottish Government to do everything possible to address the suffering of the Scottish victims of the PiP implants scandal and ensure that lessons are learned for the future, including holding a public inquiry under the Inquiries Act 2005.

What MSPs voted on: the motion as amended

Labour’s motion was rewritten by an SNP amendment (S4M-03294.1) before this vote. A vote ‘for’ was a vote for the SNP’s wording.

That the Parliament notes that an estimated 4,000 women in Scotland are believed to have received breast implants manufactured by Poly Implant Prothèse (PiP); supports the ongoing criminal investigation in France into the former owner of PiP, Jean Claude Mas, for his role in the manufacture and distribution of the substandard implants containing industrial grade silicone;

194 words removed by S4M-03294.1

further notes with concern that PiP’s activities remained undetected by regulators for a considerable period of time and the lack of information provided to the victims of the scandal, a number of whom only became aware of the potential dangers through news reports in December 2011, over a year after the medical device alert was issued by the Medicine and Healthcare products Regulatory Agency in March 2010; regrets the lottery of aftercare offered by the private clinics that carried out breast augmentation operations with PiP implants for women in Scotland, particularly the charging for replacement operations and attaching conditions to treatment such as the waiving of legal rights; further notes the Cabinet Secretary for Health, Wellbeing and Cities Strategy's assertion that it is only by chance that the NHS in Scotland did not use the potentially dangerous implants and that the true scale of the scandal in Scotland may never be known, and calls on the Scottish Government to do everything possible to address the suffering of the Scottish victims of the PiP implants scandal and ensure that lessons are learned for the future, including holding a public inquiry under the Inquiries Act 2005.

S4M-03294.1 SNP notes that the Scottish Government is working with the UK Government on the three UK-wide reviews; welcomes the findings of the report, Poly Implant Prothèse (PIP) silicone breast implants: Review of the actions of the Medicines and Healthcare products Regulatory Agency (MHRA) and Department of Health, which found that the Medicines and Healthcare products Regulatory Authority took appropriate action based on the information made available to it; looks forward to the outcome of the expert group looking at the rupture rate data and toxicology testing led by Sir Bruce Keogh, which is due to report later this month, and the review looking at the regulation of the cosmetic industry also being led by Sir Bruce Keogh, which will report by March 2013, and commends NHSScotland for the action taken by it to ensure that it responded appropriately by making information and advice available to women and ensuring that, where the private healthcare sector was unable or unwilling to provide a clinically appropriate package of care, NHSScotland provided appropriate care.

Final wording as read into the Official Report at Decision Time. The marked changes are worked out by this site from the amendment texts and match that wording.

Amendments

S4M-03294.1 SNP Michael Matheson Agreed vote, 80–1

Vote

1 division

14 Jun 2012
Women’s Health
S4M-03294as amended by SNP
Carried
80 for, 0 against, 35 abstained

Amendments

1

S4M-03294.1

Women’s Health
Michael Matheson SNP Lodged 13 Jun 2012

Carried
80 for, 1 against

Supporters

No MSP has added their name to this motion.

In the Official Report

3 contributions mention S4M-03294

14 Jun 2012

PIP Silicone Breast Implants
John Scott Con Meeting of the Parliament

The next item of business is a debate on motion S4M-03294, in the name of Jackie Baillie, on women’s health.10:27
14 Jun 2012

Decision Time
Tricia Marwick Meeting of the Parliament

The next question is, that amendment S4M-03294.1, in the name of Michael Matheson, which seeks to amend motion S4M-03294, in the name of Jackie Baillie, on women’s health, be agreed to. Are we agreed?Members: No.
14 Jun 2012

Decision Time
Tricia Marwick Meeting of the Parliament

The next question is, that motion S4M-03294, in the name of Jackie Baillie, on women’s health, as amended, be agreed to. Are we agreed? Interruption.The motion is agreed to. Interruption. Members really need to speak up. If the answer is n…